Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. Am J Cardiol. 2016 Jun 15; 117(12):1877-83.
View in:
PubMed
subject areas
Aged
Aged
Anemia
Anemia
Aspirin
Aspirin
Blood Platelets
Blood Platelets
Coronary Artery Disease
Coronary Artery Disease
Drug Therapy, Combination
Drug Therapy, Combination
Drug-Eluting Stents
Drug-Eluting Stents
Europe
Europe
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Incidence
Incidence
Male
Male
Middle Aged
Middle Aged
Myocardial Ischemia
Myocardial Ischemia
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prospective Studies
Prospective Studies
Registries
Registries
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Survival Rate
Survival Rate
Ticlopidine
Ticlopidine
United States
United States
authors with profiles
Usman Baber